ENCORE PHARMACEUTICALS INC has a total of 15 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets foods and drinks, pharmaceuticals and organic fine chemistry are DING QIANG, BEIJING MOLECULE SCIENCE AND TECHNOLOGY CO LTD and FUJI YAKUHIN CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Foods and drinks | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Foods | |
#3 | Edible oils | |
#4 | Medical preparations | |
#5 | Special foods | |
#6 | Heterocyclic compounds | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Schwartz Elaine Benaksas | 15 |
#2 | Wechter William J | 15 |
#3 | Gutierrez Israel | 7 |
#4 | Murray David E Jr | 6 |
#5 | Murray David E | 4 |
#6 | Guiterrez Israel | 3 |
#7 | Quiggle David D | 2 |
Publication | Filing date | Title |
---|---|---|
EP1592415A2 | Therapeutically active compounds | |
WO2004055200A2 | Methods for screening compounds for use in the treatment of disease | |
EP1551384A2 | R-nsaid esters and their use |